ESOMEPRAZOLE FOR THE TREATMENT OF GASTRO-OESOPHAGEAL REFLUX DISEASE IN INFANTS

(1) Clinical Development

(2) AstraZeneca LP, Wilmington

(3) Lutheran General Children's Hospital, Maywood

(4) Providence Hospital, Southfield, United States

(5) Jeanne de Flandre University Hospital, Lille, France

(6) MassGeneral Hospital for Children, Boston, United States



This item was part of the PAEDIATRIC GASTROENTEROLOGY AND HEPATOLOGY II session at Gastro 2009 UEGW/WCOG London (17th UEGW)